Press Releases
Search
-
01 Oct 2004
Appointment of an Independent Board Member - Composition of Audit and Compensation Committees
Marcy l'Etoile, France - October 1st, 2004. bioMérieux announces the nomination of a new independent Board Member, Mr Michel Angé, Vice-Président of APICIL-Prévoyance, to its Board of Directors. This ...
-
27 Sep 2004
bioMérieux innovates further in the fight against AIDS
Marcy l'Etoile, France - September 27th, 2004. A major player in the field of in vitro diagnostics, bioMérieux confirms its constant commitment to the fight against AIDS with the launch of two new adv...
-
23 Jul 2004
VIDAS® D-Dimer Exclusion™ test from bioMérieux for reliable exclusion of pulmonary embolism and deep vein thrombosis
Marcy l'Etoile, France - July 23rd, 2004. bioMérieux announces that its D-dimer assay, VIDAS D-Dimer Exclusion, is now cleared by the U.S. Food and Drug Administration (FDA) to exclude both pulmonary ...
-
21 Jul 2004
Six month report January - June 2004: Sales - in line with expectations
Marcy l'Etoile, France - July 21st, 2004. bioMérieux (Euronext : FR0010096479 – BIM) today announced: During the first six months to June 2004, bioMérieux achieved sales of Euros 461 million - an incr...
-
13 May 2004
bioMérieux laboratories grant license to Eppendorf for One Step RT-PCR technology
Marcy l'Etoile, France - May 13, 2004. Eppendorf AG, Germany, and bioMérieux, France, have concluded a non-exclusive licensing agreement for Eppendorf products using bioMérieux's exclusively controlle...
-
06 May 2004
VIDAS® D-Dimer Exclusion test from bioMérieux for reliable exclusion of venous thromboembolism
Marcy l'Etoile, France - May 6th, 2004. bioMérieux announces that following prospective management studies on its VIDAS D-Dimer test resulting in FDA approval and CE marking, the VIDAS D-Dimer New tes...